Cluster headache and arachnoid cyst
© Edvardsson and Persson; licensee Springer. 2013
Received: 19 October 2012
Accepted: 4 January 2013
Published: 10 January 2013
Cluster headache is a primary headache by definition not caused by any known underlying structural pathology. However, symptomatic cases have been described, e.g. tumours, particularly pituitary adenomas, malformations, and infections/inflammations. The evaluation of cluster headache is an issue unresolved.
We present a case of a 43-year-old patient who presented with a 2-month history of side-locked attacks of pain located in the left orbit. He satisfied the revised International Classification of Headache Disorders criteria for cluster headache. His medical and family histories were unremarkable. There was no history of headache. A diagnosis of cluster headache was made. The patient responded to symptomatic treatment. Computer tomography and enhanced magnetic resonance imaging after 1 month displayed a supra- and intrasellar arachnoid cyst with mass effect on adjacent structures. After operation, the headache attacks resolved completely.
Discussion and evaluation
Although we cannot exclude an unintentional comorbidity, in our opinion, the co-occurrence of an arachnoid cyst with mass effect with unilateral headache, in a hitherto headache-free man, points toward the fact that in this case the CH was caused or triggered by the AC. The headache attacks resolved completely after the operation and the patient also remained headache free at the follow-up. The response of the headache to sumatriptan and other typical CH medications does not exclude a secondary form. Symptomatic CHs responsive to this therapy have been described. Associated cranial lesions such as tumours have been reported in CH patients and the attacks may be clinically indistinguishable from the primary form.
Neuroimaging, preferably contrast-enhanced magnetic resonance imaging should always be considered in patients with cluster headache despite normal neurological examination. Late-onset cluster headache represents a condition that requires careful evaluation. Supra- and intrasellar arachnoid cyst can present as cluster headache.
Cluster headache (CH) is a primary headache, by definition not caused by any underlying structural pathology and belonging to the group of trigeminal-autonomic cephalalgias (Headache Subcommittee of the International Headache Society 2004). CH is the most frequent syndrome in this group. Symptomatic cases of CH have been described, e.g. tumours, particularly pituitary adenomas, malformations, and infections/inflammations (Cittadini & Matharu 2009).
Arachnoid cysts (AC) are extra-parenchymal and intra-arachnoidal collections of fluid with a composition similar to that of cerebrospinal fluid (CSF). Headaches are the most frequent complaint of patient with an AC. However, the origin of headaches is manifold and in many patients with headaches, AC must be regarded as an incidental finding (Westermaier et al. 2012).
The question whether patients with CH should undergo neuroimaging to exclude a causal underlying structural lesion is unresolved. AC causing typical CH has not been described. We report a patient with a typical CH in the setting of a supra-and intrasellar arachnoid cyst.
The case study highlights a patient with CH responding to treatment. Evaluation revealed a supra- and intrasellar arachnoid cyst with mass effect on adjacent structures. The patient satisfied the revised International Classification of Headache Disorders criteria for CH (Headache Subcommittee of the International Headache Society 2004).
Although we cannot exclude an unintentional comorbidity, in our opinion, the co-occurrence of an AC with mass effect with unilateral headache, in a hitherto headache-free man, points toward the fact that in this case the CH was caused or triggered by the AC. The headache attacks resolved completely after the operation and the patient also remained headache free at the follow-up.
The response of the headache to sumatriptan and other typical CH medications does not exclude a secondary form. Symptomatic CHs responsive to this therapy have been described (Testa et al. 2008; Ad Hoc Committee on Classification of Headache 1962). Associated cranial lesions such as tumours have been reported in CH patients and the attacks may be clinically indistinguishable from the primary form (Ad Hoc Committee on Classification of Headache 1962; Favier et al. 2007).
The pathophysiology of CH is not well known. The most widely accepted theory is that primary CH is characterized by hypothalamic activation with secondary activation of the trigeminal-autonomic reflex, probably by a trigeminal-hypothalamic pathway (Cittadini & Matharu 2009).
AC develop within the arachnoid membrane because of splitting or duplication of this membrane (Westermaier et al. 2012). Many AC are asymptomatic. Headache is related to AC producing increased intracranial pressure (ICP) and often is combined with other symptoms of increased ICP (Olesen et al. 2006). The clinical symptoms are determined by the location of the cyst (Westermaier et al. 2012).
Most cases of symptomatic CH reported have had sellar/parasellar abnormality as well as in this case. The sympathetic, parasympathetic and sensory fibers of the trigeminal nerve gather as a plexus in the sinus cavernosus/hypophyseal region. Thus, nerves in this region appear to be of importance to produce symptoms of CH (Olesen et al. 2006).
The exact pathophysiology in this CH case is unknown and one can only speculate whether an intermittent elevation of ICP might trigger or cause a disturbed local nerve function in the sinus cavernosus/hypophyseal region. (Wilbrink et al. 2009) suggest that a structural lesion may cause autonomic imbalance, resulting in periodic fluctuations in the activity of the autonomic nervous system, ultimately leading to an attack-wise presentation of the symptoms. Differences in the individual threshold for triggering the parasympathetic trigeminal reflexes may also play a role (Straube et al. 2007).
(Mainardi et al. 2010) found in their review (cases published from 1975 to 2008) of 76 patients that vascular pathologies, e.g. intracranial aneurysms and dural fistulas were the first cause of secondary CH, followed by tumours. The most frequent tumoural pathology was pituitary adenomas (prolactinomas), followed by meningiomas and carcinomas of the paranasal structures. No AC were found.
Attempts have been made to define red flags indicating a secondary cause when cluster-like headache appears for the first time (Mainardi et al. 2010). Compared with primary CH, secondary CH presents at an older age (about 42 y). A late onset represents a condition that requires careful evaluation (Mainardi et al. 2010). The authors of that study also emphasize in their report that, at first observation, 50% of patients with secondary CH presented as cases fulfilling the criteria for CH, perfectly mimicking CH. Therefore, the likelihood that a secondary cause is responsible for a clinical picture mimicking a primary CH, albeit low, should always be considered (Mainardi et al. 2010).
This opinion is in accordance with the reviews by (Favier et al. 2007) and by, (Wilbrink et al.2009) which recommend neuroimaging in all patients with trigeminal-autonomic cephalalgias. MRI is the preferred procedure for imaging in CH cases because of its greater sensitivity to vascular disease, tumour, demyelinating disease, and infections/inflammations (Wilbrink et al. 2009; Mainardi et al. 2010).
To our knowledge, this is the first report showing an association between CH and an AC. CH might be the presenting symptom of an AC even in typical forms of that headache. Neuroimaging, preferably contrast-enhanced magnetic resonance imaging should always be considered in patients with CH. Late-onset CH represents a condition that requires careful evaluation.
The principal author takes full responsibility for the data presented in this study, analysis of the data, conclusions, and conduct of the research. The principal author had full access to those data and has maintained the right to publish any and all data independent of any third party.
Concerning approval of human studies by the appropriate ethics committee and therefore performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki: In this case this is not appreciable.
- Ad Hoc Committee on Classification of Headache: Classification of headache. JAMA 1962, 179: 717-718.View ArticleGoogle Scholar
- Cittadini E, Matharu MS: Symptomatic trigeminal autonomic cephalalgias. Neurologist 2009, 15: 305-312. 10.1097/NRL.0b013e3181ad8d67View ArticleGoogle Scholar
- Favier I, van Vliet JA, Roon KI, et al.: Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol 2007, 64: 25-31. 10.1001/archneur.64.1.25View ArticleGoogle Scholar
- Headache Subcommittee of the International Headache Society: The international classification of headache disorders, 2nd edition. Cephalalgia 2004, 24(suppl 1):9-160.Google Scholar
- Mainardi F, Trucco M, Maggioni F, et al.: Cluster-like headache. A comprehensive reappraisal. Cephalalgia 2010, 30: 399-412.Google Scholar
- Olesen J, Tfelt-Hansen P, Welch KMA, Goadsby PJ, Ramadan NM: The Headaches. 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2006.Google Scholar
- Straube A, Freilinger T, Rüther T, et al.: Two cases of symptomatic cluster-like headache suggest the importance of sympathetic/parasympathetic balance. Cephalalgia 2007, 27: 1069-1073. 10.1111/j.1468-2982.2007.01348.xView ArticleGoogle Scholar
- Testa L, Mittino D, Terazzi E, et al.: Cluster-like headache and idiopathic intracranial hypertension: a case report. J Headache Pain 2008, 9: 181-183. 10.1007/s10194-008-0033-yView ArticleGoogle Scholar
- Westermaier T, Schweitzer T, Ernestus RI: Arachnoid cysts. Adv Exp Med Biol 2012, 724: 37-50. 10.1007/978-1-4614-0653-2_3View ArticleGoogle Scholar
- Wilbrink LA, Ferrari MD, Kruit MC, et al.: Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what? Curr Opin Neurol 2009, 22: 247-253. 10.1097/WCO.0b013e32832b4bb3View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.